# Imaging and multi-omics analyses to identify molecular subtypes of distinct emphysema patterns

> **NIH NIH R01** · BRIGHAM AND WOMEN'S HOSPITAL · 2024 · $880,542

## Abstract

PROJECT SUMMARY/ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disease in critical need of disease-
modifying treatments. Emphysema, progressive lung destruction commonly encountered in subjects with COPD,
portends a poor prognosis. This project will leverage two large well-phenotyped, NHLBI-funded studies (the
COPDGene and Lung Tissue Research Consortium (LTRC)) and the team’s extensive expertise in modern
imaging techniques, multi-omics data analysis, machine learning approaches, and in vitro functional validation.
The overall objective of this application is to identify novel multi-omics biomarkers and molecular subtypes of
centrilobular, panlobular, and paraseptal emphysema patterns utilizing a systems biology approach to
understand relationships between the multiple omics data types. In Aim 1, we will apply the local histogram (LH)
chest computed tomography (CT) quantification method to generate imaging phenotypes of centrilobular,
panlobular, and paraseptal emphysema in each lung lobe. We will cluster these lobar LH data to identify distinct
groups of subjects with similar LH patterns. We will then test for single-omics associations of the identified
emphysema clusters with genetic variants, DNA methylation marks, telomere length, gene expression, and
proteomics in peripheral blood and lung tissue samples. Aim 2 will develop and evaluate a lung-tissue informed,
blood-based multi-omics machine learning model for reliable clinical prediction of emphysema patterns. Timely
diagnosis calls for a blood-based predictive model as it may identify emphysema in subjects where CT scans
are not clinically indicated. This would also overcome the issues of radiation exposure and false positive findings
associated with CT scans. Aim 3 will discover molecularly-informed emphysema subtypes by applying an
innovative, interpretable, machine learning algorithm that captures directional feature interactions and provides
network representations of the molecular determinants of emphysema subtypes. We will then perform cluster
analysis on the Bivariate Shapley network representations to identify distinct subgroups of subjects based on
their graph similarity. To confirm the critical regulators of the identified pathways, we will conduct targeted gene
silencing and overexpression investigations in airway epithelial cells and lung fibroblasts. Genes will be
prioritized for functional validation utilizing existing biological knowledge and network analyses. Through a
combination of innovative, cutting-edge data generation, analytic approaches, and functional validation, this
project will make a significant contribution by enhancing emphysema phenotyping and multi-omics profiling for
a more robust prediction and a better understanding of disease pathobiology. Such knowledge will pave the way
for the development of much-needed novel and personalized therapeutic strategies.

## Key facts

- **NIH application ID:** 10912814
- **Project number:** 5R01HL167072-02
- **Recipient organization:** BRIGHAM AND WOMEN'S HOSPITAL
- **Principal Investigator:** Adel El Boueiz
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $880,542
- **Award type:** 5
- **Project period:** 2023-09-01 → 2028-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10912814

## Citation

> US National Institutes of Health, RePORTER application 10912814, Imaging and multi-omics analyses to identify molecular subtypes of distinct emphysema patterns (5R01HL167072-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10912814. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*